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1. Introduction
  Nitric oxide (NO) is an important gaseous signal molecule 
in biological tissue. Nitric oxide synthases (NOS) include 
neuronal nitric oxide synthase (nNOS or NOS1), inducible 
nitric oxide synthase (iNOS or NOS2) and endothelial 
nitric oxide synthase (eNOS or NOS3). Recently, NO has 
been found in or around the food vacuole in Plasmodium 
falciparum parasites[1], but no NOS is found in Plasmodium 
falciparum. Using the bioinformatics database and software, 
this article is to search NOS and similar proteins from 
Plasmodium berghei (Pb) and analyze their structure and 
function.
2. Materials and methods
  The gene sequence, mRNA and amino acids (aa) of NOS 
from Homo sapiens (Hs) and Mus musculus (Mm) were 
obtained from NCBI database (http://www.ncbi.nlm.nih.gov), 
then the amino acids sequences of NOS and similar proteins 
from Pb were blasted. The physical-chemical properties 
were predicted bases on http://www.expasy.org/tools/ 
protparam.html, and the molecule evolution was analyzed 
by ClustalX2. The sub-cellular localization of the protein, 
signal peptide, secondary structures, topological structure 
and 3D structure were predicted according to  http://psort.
nibb.ac.jp/ form2.html, http://www.cbs.dtu.dk/services/
SignalP/, http://www.predictprotein.org/, and http://geno3d-
pbil.ibcp.fr/cgi-bin/geno3d_automat.pl?page=/GENO3D/
geno3d_home.html, respectively.
Objective: To search and analyze nitric oxide synthase (NOS) and similar proteins from 
Plasmodium berghei(Pb). Methods: The structure and function of nitric oxide synthase and 
similar proteins from Plasmodium berghei were analyzed and predicted by bioinformatics. 
Results: PbNOS were not available, but nicotinamide adenine dinucleotide 2’-phosphate 
reduced tetrasodium (NADPH)-cytochrome p450 reductase(CPR) were gained. PbCPR was in the 
nucleus of Plasmodium berghei, while 134aa-229aa domain was localize in nucleolar organizer. 
The amino acids sequence of PbCPR had the closest genetic relationship with Plasmodium vivax 
showing a 73% homology. The tertiary structure of PbCPR displayed the forcep-shape with 
wings, but no wings existed in the tertiary structure of its’ host, Mus musculus(Mm). 137aa-200aa, 
201aa-218aa, 220aa-230aa, 232aa-248, 269aa-323aa, 478aa-501aa and 592aa-606aa domains 
of PbCPR showed no homology with MmCPRs’, and all domains were exposed on the surface of 
the protein. Conclusions: NOS can’t be found in Plasmodium berghei and other Plasmodium 
species. PbCPR may be a possible resistance site of antimalarial drug, and the targets of 
antimalarial drug and vaccine. It may be also one of the mechanisms of immune evasion. This 
study on Plasmodium berghei may be more suitable to Plasmodium vivax. And137aa-200aa, 
201aa-218aa, 220aa-230aa, 232aa-248, 269aa-323aa, 478aa-501aa and 592aa-606aa domains of 
PbCPR are more ideal targets of antimalarial drug and vaccine.
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Figure 1. Conserved domains of HsNOS, MmNOS and PbCPR.
3.2. Physical-chemical property of PbCPR
  As a non secretory protein, PbCPR is in cell nuclei, 684 aa 
in length, ans 80237.7 Da in molecular weight. It is unstable 
and the pI is 8.70.
3.3. Molecular evolution of PbCPR
  There were 397 highly conserved amino acids in PbCPR 
which were homologous to those of Plasmodium vivax 
CPR (PvCPR). The rates of consistency and similarity were 
57% and 73%, respectively. While there were 102 highly 
conserved amino acid which were homologous to those 
of Plasmodium falciparum CPR (PfCPR). And the rates of 
consistency and similarity were 27% and 48% between 
PbCPR and PfCPR. PbCPR had close relationship with PvCPR 
but distant from PfCPR, MmCPR and HsCPR(Figure 2).  
3.4. Structure of PbCPR
  毩-helics accounted for 31.7%, 毬 strands for 14.5%, 
and loop for 53.9% in the secondary structure of PbCPR. 
134aa-229aa was localized in nucleolar organizer regions 
(NORs) of Plasmodium berghei. A total of 50.58% amino 
acid were exposed on the surface of the protein. PbCPR had 
5 N-glycosylation sites, 2 cAMP- and cGMP-dependent 
protein kinase phosphorylation sites, 14 protein kinase C 
phosphorylation sites, 6 casein kinase II phosphorylation 
sites, 3 tyrosine kinase phosphorylation sites, and 1 
N-myristoylation site (Figure 3 and 4). 
  The tertiary structure of PbCPR showed forceps with wings. 
Conserved domaind of FMN-red superfamily and FNR-like 
superfamily formed a huge and deep fracture. 134aa-229aa 
was localized in upper left of the back of the protein. Most 
functional sites scattered on the surface of the protein(Figure 
4).
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Figure 2. Molecular evolution analysis of PbCPR.
3.Results 
3.1. PbNOS and similar proteins
  The accession number of the gene, mRNA and aa of HsNOS 
and MmNOS were listed in  Table 1. 
  No protein with similar mRNA or aa to HsNOS and MmNOS 
was found in Pb and other Plasmodium species, but 
nicotinamide adenine dinucleotide 2’-phosphate reduced 
tetrasodium (NADPH)NADPH-cytochrome p450 reductase 
(CYPOR or CPR) of Pb was found in part similar to HsNOS and 
MmNOS. Gene ID of PbCPR was 3426618, and the accession 
number of mRNA and aa of PbCPR were XM_672962.1 and 
XP_678054.1. The amino acid sequence of PbCPR was really 
just like C-terminal amino acid sequence of HsNOS and 
MmNOS, which includes FNR-like superfamily and FMN-
red superfamily. PbCPR 1aa-144aa was located in conserved 
domains of  FMN-red superfamily, while 323aa-684aa in 
domains of FNR-like superfamily(Table 2 and Figure 1).
Table 1  
Accession number of the gene, mRNA and aa of HsNOS and MmNOS.
NOS1 NOS2 NOS3
Hs Mm Hs Mm Hs Mm
Gene NG_011991.1 - NG_011470.1 - NG_011992.1 -
mRNA NM_000620.2 NM_008712.2 NM_000625.4 NM_010927.3 NM_000603.4 NM_008713.4
Amino acids NP_000611.1 NP_032738.1 NP_000616.3 NP_035057.1 NP_000594.2 NP_032739.3
Table 2  
Similarity of amino acid sequence of Pb CPR, HsNOS and MmNOS.
Sequence Sequence Sequence
Pb CPR     1 - 136 349 - 655 Pb CPR     1 - 144 349 - 658 Pb CPR      1 - 136 349 - 655 
HsNOS1 769 - 941 1092 - 1367 HsNOS2 548 - 686 821 - 1098 HsNOS3  529 - 704 852 - 1127 
Pb CPR     1 - 142 349 - 638 PbCPR     1 - 144 342 - 680 Pb CPR      1 - 655                -
MmNOS1 764 - 942 1087 - 1362 MmNOS2 349 - 658 815 - 1092 MmNOS3  528 - 1126              -
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3.5. Comparison of PbCPR and MmCPR 
  PbCPR was in cell nuclei, while MmCPR was in cytoplasm. 
89aa-233aa of MmCPR and 1aa-144aa of PbCPR lied 
in conserved domain of FMN-red superfamily with 49 
homolougous highly conserved amino acids. The rates of 
consistency and similarity were 31% and 54% between 
PbCPR and PvCPR. 343-677aa of MmCPR and 323aa- 684aa 
of PbCPR lied in conservative structure domain of FNR-like 
suoerfamily with 103 homologous highly conserved amino 
acids. The rates of consistency and similarity were 26% 
and 47% between PbCPR and PvCPR. The tertiary structure 
of PbCPR showed forceps with wings, but no wings in the 
tertiary structure of MmCPR (Figure 5).
Figure 3. Secondary structure of PbCPR.
Red alphabet represent conserved amino acid residue,  
=conserved domain, H=毩 helics, E=毬 strands, e = exposed, 
N=NORs, = N-glycosylation site, = cAMP- and cGMP-
dependent protein kinase phosphorylation site,    and
= Protein kinase C phosphorylation site, = Casein kinase II 
phosphorylation site, = Tyrosine kinase phosphorylation site, 
= N-myristoylation site.
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Figure 4. Tertiary structure of PbCPR.
Red = NORs, tan = FMN-red superfamily, dchre = FNR-like 
superfamily, blue = non domain, pink = N-glycosylation site, grass 
green = cAMP- and cGMP-dependent protein kinase phosphorylation 
site, yellow = Protein kinase C phosphorylation site, black green 
= Casein kinase II phosphorylation site, gray = Tyrosine kinase 
phosphorylation site, cyan = N-myristoylation site.
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Figure 5. Comparison between the structure of PbCPR and MmCPR.
A and B represent PbCPR and MmCPR, respectively 1 and 2 
represent the front and the side, respectively.
3.6. Unique sites of PbCPR
  137aa-200aa, 201aa-218aa, 220aa-230aa, 232aa-248 aa, 
269aa-323aa, 478aa-501aa and 592aa-606aa of PbCPR were 
expose on the surface of the protein, and had no homology 
to MmCPR. 137aa-200aa, 201aa-218aa and 220aa-230aa 
were located in NORs. 232aa-248aa and 269aa- 323aa 
were in front of the left winglike structure of the protein, 
478aa-501aa was in the right, 592aa-606 aa was in the 
undersurface(Figure 3 and 6).
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Figure 6. Unique sites of PbCPR. 
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  White = highly similar with other species; other colors= the 
unique sites of PbCPR; red = NORs, blue = non functional 
sites; purple = N-glycosylation site; yellow = Protein 
kinase C phosphorylation site; green = Casein kinase II 
phosphorylation site; grey = Tyrosine kinase phosphorylation 
site; cyan= N-myristoylation site.
4. Discussion
  NO widely exists in organisms. It is an important 
signal molecule and the key factor in the anti-malarial 
mechanism[2]. NOS is an important enzyme in NO synthesis 
process, and mainly provide the NO which participates in 
inhabiting or killing Plasmodium[3,4]. NOS can be found in 
both normal red blood cell (RBC)[5] and Plasmodium infected 
RBC[6]. Recently, NO has been found in Plasmodium. NOS 
of Pb and other Plasmodium species are not available in 
bioinformatics retrieval, whereas CPR partly similar to 
HsNOS and MmNOS can be gained. Therefore, Plasmodium 
including Pb may have no NOS gene, and NO in Plasmodium 
may originate mainly from other sources. 
  Both CPR and NOS belong to the family of diflavin 
reductases[7]. The main function of CPR are transporting 
electron and taking part in drug metabolism. CPR provides 
electron transport to cytochrome P450 monooxygenase 
system, cytochrome C, cytochrome b5, heme oxidase, 
squalen monooxygenase and 7-dehydrocholesterole 
reductase. It can catalyze reductive metabolism of 
prodrugs[8], and produce reactive oxygen species (ROS) by 
oxidation of NADPH[9]. Gene mutation of CPR causes Antley- 
Bixler syndrome (ABS) that is an autosomal recessive 
hereditary disease, developmental disability, disorders of 
drug metabolism, etc[10-13].
  It is predicted by bioinformatics analysis that different 
from MmCPR which is in cytoplasm, PbCPR is located in cell 
nucleus, and has 14% sequence locating in NORs forming 
section. It is still possible that the subcellular localization of 
PbCPR may be one immune evasion mechanism. 
  Amino acids sequence alignment and evolution analysis 
indicates that PbCPR has closest relationship with PvCPR, 
but distant from PfCPR. Therefore, the study on Plasmodium 
berghei may be more suitable to Plasodium vivax than 
Plasmodium falciparum. 
  It is still unclear now what kind of role CPR of Plasmodium 
species play in the growth and reproduce of Plasmodium 
species, and how CPR gene mutation affect the growth and 
reproduce of Plasmodium species. Considering the role of 
CPR in electron transporting and drugs metabolism, it can’t 
rule out the possibility that CPR of Plasmodium species may 
be target for potential anti-malaria drug and vaccine, and 
the possible resistance sites of anti-malaria drug. According 
to amino acids sequence, subcellular localization of PbCPR 
and MmCPR, the function of CPR and these diseases due 
to CPR gene mutation in mammals, it can be concluded 
that PbCPR is a possible target for drugs and vaccines, 
with137aa-200aa, 201aa-218aa, 220aa-230aa, 232aa-248, 
269aa-323aa, 478aa-501 aa and 592aa -606aa being the ideal 
target domains.
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